gms | German Medical Science

102. Jahrestagung der DOG

Deutsche Ophthalmologische Gesellschaft e. V.

23. bis 26.09.2004, Berlin

Current concepts in the management of retinal vein occlusion: a step toward evidence-based care

Meeting Abstract

Search Medline for

  • corresponding author L.-O. Hattenbach - Klinik für Augenheilkunde, Klinikum der Johann-Wolfgang-Goethe-Universität, Frankfurt am Main

Evidenzbasierte Medizin - Anspruch und Wirklichkeit. 102. Jahrestagung der Deutschen Ophthalmologischen Gesellschaft. Berlin, 23.-26.09.2004. Düsseldorf, Köln: German Medical Science; 2004. Doc04dogFR.01.01

The electronic version of this article is the complete one and can be found online at:

Published: September 22, 2004

© 2004 Hattenbach.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.



To date, there is still no consensus among ophthalmologists about the therapeutic approach in retinal vein occlusion.

Thus far, thermal photocoagulation to prevent ocular neovascularization and drug therapies including hemodilution, thrombolysis, or the use of antiplatelet or anticoagulant agents have been the mainstay in therapy. During the past years, numerous surgical approaches such as adventitial sheathotomy, radial neurotomy, or the intravitreal application of steroids have improved our armamentarium of treatment strategies for the management of branch or central retinal vein occlusion.

However, only a few studies have attempted to prove the effectiveness of these therapeutic approaches in a randomized manner. Here, available data on the management of retinal vein occlusion are reviewed to determine whether current treatment options are likely to improve major clinical outcomes and to provide an evidence-based framework for decision-making strategies. Moreover, ongoing clinical trials and novel therapeutic approaches are presented.